# Ark Investment Management

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/ark-investment-management
Canonical HTML page: https://getbiobrief.com/entity/ark-investment-management

## Recent coverage (1 stories)

### ARK Invest Doubles Down on Tempus AI Amid Precision Medicine Volatility
2026-03-16 00:32:42 · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Cathie Wood's ARK Investment Management has purchased $2 million worth of Tempus AI shares, reinforcing its position in the precision medicine firm despite a 15% year-to-date decline. The move underscores Wood's commitment to 'coiled spring' AI and biotech assets, even as her flagship funds face significant performance headwinds compared to the broader market.
Full story: https://getbiobrief.com/story/ark-invest-tempus-ai-purchase-precision-medicine

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.